Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Federal Reserve officials weighed the strength of the labor market as January payrolls edge higher, creating a tense ...
NVIDIA beat estimates with $68.1 billion in Q4 revenue and strong Q1 guidance, led by data-center demand. Analysts we...
When a senior executive sells thousands of shares, investors often jump to conclusions. This article breaks down what...
Pi Network’s token jumped 8.5% in today’s session, rising to a multi-week high as upgrades roll out and unlock schedu...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
Oil prices edge higher around $99 a barrel on March 12, 2026, as markets assess supply constraints and demand trends....
Three BDCs flash double-digit yields, but sustainability varies. FSK and SCM face earnings pressure and dividend cuts...
Offerpad rolls out two internal AI platforms, SCOUT and HENRY, as the company pursues 1,000 quarterly home transactio...
Lemonade stock surged about 16% this week thanks to a powerful mix of analyst optimism and progress in its AI-based u...
Barclays slashed Molson Coors' price target to $40, underscoring earnings headwinds as the brewer anticipates a tough...